{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:31:18Z","timestamp":1790447478698,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010099","name":"\u00dastav organick\u00e9 chemie a biochemie Akademie v\u011bd \u010cesk\u00e9 republiky","doi-asserted-by":"publisher","award":["61388963"],"award-info":[{"award-number":["61388963"]}],"id":[{"id":"10.13039\/501100010099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010099","name":"Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010099","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Monkeypox, or mpox, is a disease that has recently resurfaced and spread across the globe. Despite the availability of an FDA-approved vaccine (JYNNEOS) and an effective drug (tecovirimat), concerns remain over the possible recurrence of a viral pandemic. Like any other virus, mpox virus must overcome the immune system to replicate. Viruses have evolved various strategies to overcome both innate and adaptive immunity. Poxviruses possess an unusual nuclease, poxin, which cleaves 2'-3'-cGAMP, a cyclic dinucleotide, which is an important second messenger in the cGAS-STING signaling pathway. Here, we present the crystal structure of mpox poxin. The structure reveals a conserved, predominantly \u03b2-sheet fold and highlights the high conservation of the cGAMP binding site and of the catalytic residues His17, Tyr138, and Lys142. This research suggests that poxin inhibitors could be effective against multiple poxviruses.<\/jats:p>","DOI":"10.1007\/s00705-023-05824-4","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T11:03:08Z","timestamp":1687950188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Structure of monkeypox virus poxin: implications for drug design"],"prefix":"10.1007","volume":"168","author":[{"given":"Vojtech","family":"Duchoslav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9652-4065","authenticated-orcid":false,"given":"Evzen","family":"Boura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"5824_CR1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2208860","author":"A Gessain","year":"2022","unstructured":"Gessain A, Nakoune E, Yazdanpanah Y (2022) Monkeypox. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMra2208860","journal-title":"N Engl J Med"},{"issue":"2","key":"5824_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010141","volume":"16","author":"EM Bunge","year":"2022","unstructured":"Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R (2022) The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis 16(2):e0010141","journal-title":"PLoS Negl Trop Dis"},{"issue":"22","key":"5824_CR3","doi-asserted-by":"publisher","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","volume":"71","author":"AK Rao","year":"2022","unstructured":"Rao AK, Petersen BW, Whitehill F, Razeq JH, Isaacs SN, Merchlinsky MJ, Campos-Outcalt D, Morgan RL, Damon I, Sanchez PJ, Bell BP (2022) Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the advisory committee on immunization practices-United States, 2022. Mmwr-Morbidity and Mortality Weekly Report 71(22):734\u2013742","journal-title":"Mmwr-Morbidity and Mortality Weekly Report"},{"issue":"3","key":"5824_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","volume":"19","author":"AT Russo","year":"2021","unstructured":"Russo AT, Grosenbach DW, Chinsangaram J, Honeychurch KM, Long PG, Lovejoy C, Maiti B, Meara I, Hruby DE (2021) An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther 19(3):331\u2013344","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5824_CR5","doi-asserted-by":"publisher","first-page":"114316","DOI":"10.1016\/j.bcp.2020.114316","volume":"183","author":"M Carty","year":"2021","unstructured":"Carty M, Guy C, Bowie AG (2021) Detection of viral infections by innate immunity. Biochem Pharmacol 183:114316","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"5824_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000503030","volume":"12","author":"M Kikkert","year":"2020","unstructured":"Kikkert M (2020) Innate immune evasion by human respiratory RNA viruses. J Innate Immun 12(1):4\u201320","journal-title":"J Innate Immun"},{"issue":"44","key":"5824_CR7","doi-asserted-by":"publisher","first-page":"15158","DOI":"10.1074\/jbc.REV120.012317","volume":"295","author":"RP Staudt","year":"2020","unstructured":"Staudt RP, Alvarado JJ, Emert-Sedlak LA, Shi HB, Shu ST, Wales TE, Engen JR, Smithgall TE (2020) Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes. J Biol Chem 295(44):15158\u201315171","journal-title":"J Biol Chem"},{"issue":"2","key":"5824_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/nar\/gkab1279","volume":"50","author":"R Nencka","year":"2022","unstructured":"Nencka R, Silhan J, Klima M, Otava T, Kocek H, Krafcikova P, Boura E (2022) Coronaviral RNA-methyltransferases: function, structure and inhibition. Nucleic Acids Res 50(2):635\u2013650","journal-title":"Nucleic Acids Res"},{"key":"5824_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1720","author":"N Li","year":"2022","unstructured":"Li N, Rana TM (2022) Regulation of antiviral innate immunity by chemical modification of viral RNA. Wiley Interdiscip Rev-RNA. https:\/\/doi.org\/10.1002\/wrna.1720","journal-title":"Wiley Interdiscip Rev-RNA"},{"issue":"5","key":"5824_CR10","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/S0021-9258(17)34923-2","volume":"253","author":"S Muthukrishnan","year":"1978","unstructured":"Muthukrishnan S, Moss B, Cooper JA, Maxwell ES (1978) Influence of 5\u2019-terminal cap structure on initiation of translation of vaccinia virus messenger-RNA. J Biol Chem 253(5):1710\u20131715","journal-title":"J Biol Chem"},{"key":"5824_CR11","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.virol.2015.02.007","volume":"479","author":"E Abernathy","year":"2015","unstructured":"Abernathy E, Glaunsinger B (2015) Emerging roles for RNA degradation in viral replication and antiviral defense. Virology 479:600\u2013608","journal-title":"Virology"},{"issue":"7","key":"5824_CR12","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/biomedicines9070765","volume":"9","author":"HB Yu","year":"2021","unstructured":"Yu HB, Bruneau RC, Brennan G, Rothenburg S (2021) Battle royale: innate recognition of poxviruses and viral immune evasion. Biomedicines 9(7):765","journal-title":"Biomedicines"},{"issue":"7743","key":"5824_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-019-0928-6","volume":"566","author":"JB Eaglesham","year":"2019","unstructured":"Eaglesham JB, Pan YD, Kupper TS, Kranzusch PJ (2019) Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS-STING signalling. Nature 566(7743):259","journal-title":"Nature"},{"issue":"3","key":"5824_CR14","doi-asserted-by":"publisher","first-page":"e1009372","DOI":"10.1371\/journal.ppat.1009372","volume":"17","author":"CM de Motes","year":"2021","unstructured":"de Motes CM (2021) Poxvirus cGAMP nucleases: clues and mysteries from a stolen gene. PLoS Pathog 17(3):e1009372","journal-title":"PLoS Pathog"},{"key":"5824_CR15","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.59753","author":"JB Eaglesham","year":"2020","unstructured":"Eaglesham JB, McCarty KL, Kranzusch PJ (2020) Structures of diverse poxin cGAMP nucleases reveal a widespread role for cGAS-STING evasion in host-pathogen conflict. Elife. https:\/\/doi.org\/10.7554\/eLife.59753","journal-title":"Elife"},{"issue":"7454","key":"5824_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature12306","volume":"498","author":"A Ablasser","year":"2013","unstructured":"Ablasser A, Goldeck M, Cavlar T, Deimling T, Witte G, Rohl I, Hopfner KP, Ludwig J, Hornung V (2013) cGAS produces a 2 \u2019-5 \u2019-linked cyclic dinucleotide second messenger that activates STING. Nature 498(7454):380","journal-title":"Nature"},{"key":"5824_CR17","doi-asserted-by":"publisher","first-page":"113831","DOI":"10.1016\/j.bcp.2020.113831","volume":"174","author":"T Phelan","year":"2020","unstructured":"Phelan T, Little MA, Brady G (2020) Targeting of the cGAS-STING system by DNA viruses. Biochem Pharmacol 174:113831","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"5824_CR18","doi-asserted-by":"publisher","first-page":"17309","DOI":"10.1038\/s41598-017-17621-6","volume":"7","author":"A Dubankova","year":"2017","unstructured":"Dubankova A, Humpolickova J, Klima M, Boura E (2017) Negative charge and membrane-tethered viral 3B cooperate to recruit viral RNA dependent RNA polymerase 3D (pol). Sci Rep 7(1):17309","journal-title":"Sci Rep"},{"issue":"6","key":"5824_CR19","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.3390\/molecules27061894","volume":"27","author":"E Konkolova","year":"2022","unstructured":"Konkolova E, Krejcova K, Eyer L, Hodek J, Zgarbova M, Fortova A, Jirasek M, Teply F, Reyes-Gutierrez PE, Ruzek D, Weber J, Boura E (2022) A Helquat-like compound as a potent inhibitor of flaviviral and coronaviral polymerases. Molecules 27(6):1894","journal-title":"Molecules"},{"issue":"12","key":"5824_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01226-22","volume":"66","author":"CE DeLaurentis","year":"2022","unstructured":"DeLaurentis CE, Kiser J, Zucker J (2022) New perspectives on antimicrobial agents: tecovirimat for treatment of human Monkeypox virus. Antimicrob Agents Chemother 66(12):e0122622","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5824_CR21","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.vaccine.2019.10.049","volume":"38","author":"AT Russo","year":"2020","unstructured":"Russo AT, Berhanu A, Bigger CB, Prigge J, Silvera PM, Grosenbach DW, Hruby D (2020) Co-administration of tecovirimat and ACAM2000 in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge. Vaccine 38(3):644\u2013654","journal-title":"Vaccine"},{"issue":"8","key":"5824_CR22","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1021\/acsinfecdis.1c00131","volume":"7","author":"T Otava","year":"2021","unstructured":"Otava T, Sala M, Li F, Fanfrlik J, Devkota K, Perveen S, Chau I, Pakarian P, Hobza P, Vedadi M, Boura E, Nencka R (2021) The structure-based design of SARS-CoV-2 nsp14 methyltransferase ligands yields nanomolar inhibitors. ACS Infect Dis 7(8):2214\u20132220","journal-title":"ACS Infect Dis"},{"issue":"9","key":"5824_CR23","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.1002\/pro.4395","volume":"31","author":"M Klima","year":"2022","unstructured":"Klima M, Khalili Yazdi A, Li F, Chau I, Hajian T, Bolotokova A, Kaniskan HU, Han Y, Wang K, Li D, Luo M, Jin J, Boura E, Vedadi M (2022) Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16. Protein Sci 31(9):4395","journal-title":"Protein Sci"},{"issue":"4","key":"5824_CR24","doi-asserted-by":"publisher","first-page":"130319","DOI":"10.1016\/j.bbagen.2023.130319","volume":"1867","author":"F Li","year":"2023","unstructured":"Li F, Ghiabi P, Hajian T, Klima M, Li ASM, Khalili Yazdi A, Chau I, Loppnau P, Kutera M, Seitova A, Bolotokova A, Hutchinson A, Perveen S, Boura E, Vedadi M (2023) SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses. Biochim Biophys Acta Gen Subj 1867(4):130319","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"5824_CR25","first-page":"36","volume":"5","author":"K Devkota","year":"2021","unstructured":"Devkota K, Schapira M, Perveen S, Khalili Yazdi A, Li F, Chau I, Ghiabi P, Hajian T, Loppnau P, Bolotokova A, Satchell KJF, Wang K, Li D, Liu J, Smil D, Luo M, Jin J, Fish PV, Brown PJ, Vedadi M (2021) Probing the SAM binding site of SARS-CoV-2 Nsp14 in vitro using SAM competitive inhibitors guides developing selective bisubstrate inhibitors. SLAS Discov 5:36","journal-title":"SLAS Discov"},{"issue":"1","key":"5824_CR26","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1038\/s41467-023-38019-1","volume":"14","author":"J Silhan","year":"2023","unstructured":"Silhan J, Klima M, Otava T, Skvara P, Chalupska D, Chalupsky K, Kozic J, Nencka R, Boura E (2023) Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase. Nat Commun 14(1):2259","journal-title":"Nat Commun"},{"issue":"1","key":"5824_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/COH.0000000000000713","volume":"17","author":"H Dvory-Sobol","year":"2022","unstructured":"Dvory-Sobol H, Shaik N, Callebaut C, Rhee MS (2022) Lenacapavir: a first-in-class HIV-1 capsid inhibitor. Curr Opin HIV AIDS 17(1):15\u201321","journal-title":"Curr Opin HIV AIDS"},{"issue":"19","key":"5824_CR28","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJMoa2115542","volume":"386","author":"S Segal-Maurer","year":"2022","unstructured":"Segal-Maurer S, DeJesus E, Stellbrink HJ, Castagna A, Richmond GJ, Sinclair GI, Siripassorn K, Ruane PJ, Berhe M, Wang H, Margot NA, Dvory-Sobol H, Hyland RH, Brainard DM, Rhee MS, Baeten JM, Molina JM (2022) Capsid Inhibition with lenacapavir in multidrug-resistant HIV-1 infection. N Engl J Med 386(19):1793\u20131803","journal-title":"N Engl J Med"},{"issue":"48","key":"5824_CR29","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/acs.biochem.1c00692","volume":"60","author":"B Novotna","year":"2021","unstructured":"Novotna B, Hola L, Stas M, Gutten O, Smola M, Zavrel M, Vavrina Z, Budesinsky M, Liboska R, Chevrier F, Dobias J, Boura E, Rulisek L, Birkus G (2021) Enzymatic synthesis of 3\u2019-5\u2019, 3\u2019-5\u2019 cyclic dinucleotides, their binding properties to the stimulator of interferon genes adaptor protein, and structure\/activity correlations. Biochemistry 60(48):3714\u20133727","journal-title":"Biochemistry"},{"issue":"11","key":"5824_CR30","doi-asserted-by":"publisher","first-page":"7596","DOI":"10.1021\/acs.jmedchem.1c00301","volume":"64","author":"M Pimkova Polidarova","year":"2021","unstructured":"Pimkova Polidarova M, Brehova P, Kaiser MM, Smola M, Dracinsky M, Smith J, Marek A, Dejmek M, Sala M, Gutten O, Rulisek L, Novotna B, Brazdova A, Janeba Z, Nencka R, Boura E, Pav O, Birkus G (2021) Synthesis and biological evaluation of phosphoester and phosphorothioate prodrugs of STING agonist 3\u2019,3\u2019-c-Di(2\u2019F,2\u2019dAMP). J Med Chem 64(11):7596\u20137616","journal-title":"J Med Chem"},{"issue":"18","key":"5824_CR31","doi-asserted-by":"publisher","first-page":"10172","DOI":"10.1002\/anie.202016805","volume":"60","author":"M Smola","year":"2021","unstructured":"Smola M, Gutten O, Dejmek M, Kozisek M, Evangelidis T, Tehrani ZA, Novotna B, Nencka R, Birkus G, Rulisek L, Boura E (2021) Ligand strain and its conformational complexity is a major factor in the binding of cyclic dinucleotides to STING protein. Angew Chem Int Ed Engl 60(18):10172\u201310178","journal-title":"Angew Chem Int Ed Engl"},{"issue":"8","key":"5824_CR32","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.str.2022.05.012","volume":"30","author":"M Dejmek","year":"2022","unstructured":"Dejmek M, Sala M, Brazdova A, Vanekova L, Smola M, Klima M, Brehova P, Budesinsky M, Dracinsky M, Prochazkova E, Zavrel M, Simak O, Pav O, Boura E, Birkus G, Nencka R (2022) Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential. Structure 30(8):1146\u20131156","journal-title":"Structure"},{"issue":"40","key":"5824_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202207175","volume":"61","author":"S Stazzoni","year":"2022","unstructured":"Stazzoni S, Bohmer DFR, Hernichel F, Ozdemir D, Pappa A, Drexler D, Bauernfried S, Witte G, Wagner M, Veth S, Hopfner KP, Hornung V, Konig LM, Carell T (2022) Novel Poxin Stable cGAMP-Derivatives Are Remarkable STING Agonists. Angew Chem Int Ed Engl 61(40):e202207175","journal-title":"Angew Chem Int Ed Engl"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-023-05824-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-023-05824-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-023-05824-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T23:34:26Z","timestamp":1689809666000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-023-05824-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["5824"],"URL":"https:\/\/doi.org\/10.1007\/s00705-023-05824-4","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]},"assertion":[{"value":"20 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"192"}}